Sensitization of Member States on WHO-UNICEF Estimates of National Immunization Coverage (WUENIC) methodology and process

20 – 21 January 2025

 

The electronic Joint Reporting Form (eJRF) serves as the primary source for vaccination coverage data globally, which WHO-HQ and UNICEF-HQ jointly compile to produce the WHO-UNICEF Estimates of National Immunization Coverage (WUENIC). WUENIC estimates are crucial in guiding and evaluating immunization programs and assessing progress in eliminating and controlling vaccine-preventable diseases in all Member States of the WHO South-East Asia Region (SEAR). However, at times, there is limited awareness and understanding among Member States regarding the methodology used for these estimates.

Group Photo of a Virtual meeting

WHO organized an orientation webinar for key stakeholders to enhance understanding and strengthen capacity among Member States on the WUENIC estimation process. The objective of this orientation webinar is to provide awareness and sensitization to the immunization stakeholders of the region on methodology of this estimation process. To encourage active participation from all countries and ensure comprehensive engagement, the webinar was conducted virtually in two batches, allowing WHO to effectively address queries and provide detailed explanations.

Batch 1 on 20th January 2025 from 1300-1500 hours (IST) – Bhutan, DPR Korea, India, Maldives and Nepal

Batch 2 on 21st January 2025 from 1300-1500 hours (IST) – Bangladesh, Indonesia, Myanmar, Sri Lanka, Thailand and Timor-Leste

Member States from all eleven countries of the region actively participated in the webinar, along with over 100 representatives from governments, WHO, UNICEF, and other partner agencies. Following are some key deliberations from the webinar: 

Key deliberations from the webinar

The orientation session informed participants that the WUENIC Working Group (WWG), comprising experts from WHO-HQ and UNICEF-HQ, methodology of WUENIC estimates, and review process. WUENIC estimates are derived from reported coverage, national best estimates, coverage surveys, published and grey literature, and contextual factors such as data quality audits, expert opinions, local knowledge, and stockouts. 

Estimates of routine immunization coverage

Historical estimates are revised using the most recent data available. Estimates for regional, global, and other country groups are derived from official population estimates and projections by the United Nations Population Division (source: UN Population Division). The WUENIC Methodology Publications are featured in several scientific journals, listed below.

The strengths of WUENIC estimates lie in their use of country-specific data, which ensures contextual relevance, and the incorporation of programmatic information for more accurate projections. Additionally, the Grade of Confidence adds reliability to the estimates. However, there are limitations, as estimates are influenced by the quality of underlying data, and uncertainty is not quantitatively estimated. More recent year estimates often rely on fewer data sources, with earlier years benefiting from more robust survey data. Historical series are revised as new data emerges.

WUENIC products

Timeline

After discussions on WUENIC estimation methodology for different vaccine antigens, methodology of estimation methodology of Human Papillomavirus Vaccine (HPV) coverage was discussed in detail. Like other vaccine antigens numerator for HPV is derived from reported data through eJRF and other data sources. However, denominator is not taken from reported population data but official United Nations population estimates and projections are used as denominator for HPV coverage estimates. Estimation methodology of programme  coverage of HPV as a short-term performance and methodology of coverage by age 15 years as long-term performance was explained. Also discussed was the difference and merging of first dose coverage estimate and final dose coverage estimate based on HPV dose schedule in the country. 

Annual process of the HPV estimates development

graph showing the regional HPV programme status

Two indicators if HPV vaccine coverage

Limitations: Currently, most country HPV coverage estimates are solely based on reported administrative data. To improve the accuracy of these estimates, HPV data from coverage surveys is necessary to triangulate and validate the administrative data, similar to the approach used by WUENIC for childhood vaccines. HPV modules are available for EPI coverage surveys, DHS, MICS, and GSHS. It is crucial to ensure that the HPV vaccine is included in planned coverage surveys to enhance the quality of estimates.

Participants were interactive and there were quite a few queries regarding the methodology of immunization coverage estimation, especially HPV.